Regular aspirin use may decrease the risk of death from cardiovascular disease (CVD) and all causes among individuals with type 2 diabetes, according to a study.

Investigators followed 651 type 2 diabetics with no prior CVD history until death or the end of June 2007. Of these subjects, 160 (24.6%) died, 70 (43.8%) from CVD.

After adjusting for significant variables, regular use of aspirin (75 mg/day or more) at baseline was independently associated with a 70% and 47% decreased risk of CVD and all-cause mortality, respectively, the researchers reported in Diabetes Care (2009; published online ahead of print). In subgroup analyses, aspirin use was independently associated with decreased all-cause mortality among men and subjects aged 65 years and older.

Continue Reading

From the January 01, 2010 Issue of Renal and Urology News

Topics:

Diabetes Epidemiology